AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

72

VANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera will apply single-cell screening of natural immune sources to generate panels of therapeutic antibody candidates for evaluation by Gilead.

 

 

http://www.businesswire.com/news/home/20190613005003/en/AbCellera-Announces-Therapeutic-Antibody-Discovery-Collaboration-Gilead/